Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

MoonLake Immunotherapeutics (MLTX) Shares Issued (2021 - 2026)

MoonLake Immunotherapeutics' Shares Issued history spans 6 years, with the latest figure at $6.0 million for Q1 2026.

  • Quarterly Shares Issued changed N/A to $6.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $78.4 million through Mar 2026, up 85774.83% year-over-year, with the annual reading at $72.4 million for FY2025, 37.79% up from the prior year.
  • Shares Issued came in at $6.0 million for Q1 2026, down from $72.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $482.5 million in Q4 2023 to a low of -$451.3 million in Q3 2023.
  • The 5-year median for Shares Issued is $100000.0 (2025), against an average of $16.1 million.
  • Year-over-year, Shares Issued skyrocketed 385222.66% in 2023 and then crashed 209.53% in 2025.
  • MoonLake Immunotherapeutics' Shares Issued stood at -$3791.0 in 2022, then soared by 12726399.13% to $482.5 million in 2023, then crashed by 99.98% to $91298.0 in 2024, then soared by 79195.27% to $72.4 million in 2025, then crashed by 91.7% to $6.0 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Shares Issued are $6.0 million (Q1 2026), $72.4 million (Q4 2025), and -$100000.0 (Q3 2025).